Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini… - The lancet …, 2010 - thelancet.com
Background Human papillomavirus (HPV) testing is known to be more sensitive, but less
specific than cytology for detecting cervical intraepithelial neoplasia (CIN). We assessed the …

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

DC Rijkaart, J Berkhof, L Rozendaal… - The lancet …, 2012 - thelancet.com
Background Human papillomavirus (HPV) testing is more sensitive for the detection of high-
grade cervical lesions than is cytology, but detection of HPV by DNA screening in two …

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled …

NWJ Bulkmans, J Berkhof, L Rozendaal… - The Lancet, 2007 - thelancet.com
Background Tests for the DNA of high-risk types of human papillomavirus (HPV) have a
higher sensitivity for cervical intraepithelial neoplasia grade 3 or worse (CIN3+) than does …

Management of women who test positive for high-risk types of human papillomavirus: the HART study

J Cuzick, A Szarewski, H Cubie, G Hulman… - The Lancet, 2003 - thelancet.com
Background Certain types of human papillomavirus (HPV) are the primary cause of almost
all cervical cancers. HPV testing of cervical smears is more sensitive but less specific than …

Human papillomavirus testing in primary cervical screening

J Cuzick, A Szarewski, G Terry, A Hanby, P Maddox… - The Lancet, 1995 - thelancet.com
Several studies have examined the role of tests for human papillomavirus (HPV) in
screening for cervical cancer but as yet the relevance is unclear. We looked at HPV testing …

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

P Naucler, W Ryd, S Törnberg, A Strand… - … England Journal of …, 2007 - Mass Medical Soc
Background Screening for cervical cancer based on testing for human papillomavirus (HPV)
increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial …

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

HC Kitchener, M Almonte, C Thomson… - The lancet …, 2009 - thelancet.com
Background Testing for human papillomavirus (HPV) DNA is reportedly more sensitive than
cytology for the detection of high-grade cervical intraepithelial neoplasia (CIN). The …

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer …

G Ronco, P Giorgi-Rossi, F Carozzi… - Journal of the …, 2008 - academic.oup.com
Background In the first recruitment phase of a randomized trial of cervical cancer screening
methods (New Technologies for Cervical Cancer Screening [NTCC] study), we compared …

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

G Ronco, J Dillner, KM Elfström, S Tunesi, PJF Snijders… - The lancet, 2014 - thelancet.com
Background In four randomised trials, human papillomavirus (HPV)-based screening for
cervical cancer was compared with cytology-based cervical screening, and precursors of …

Human papillomavirus testing versus cytology in primary cervical cancer screening: End‐of‐study and extended follow‐up results from the Canadian cervical cancer …

SD Isidean, MH Mayrand… - … journal of cancer, 2016 - Wiley Online Library
The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …